Breakdown | TTM | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 2.79B | 2.71B | 2.54B | 2.01B | 1.67B | 1.52B |
Gross Profit | 184.25M | 182.35M | 170.84M | 127.72M | 100.55M | 87.73M |
EBITDA | 24.20M | 27.37M | 33.43M | 26.25M | 20.92M | 12.68M |
Net Income | 1.48M | 4.34M | 11.60M | 16.67M | 12.19M | 5.54M |
Balance Sheet | ||||||
Total Assets | 392.00M | 374.11M | 363.43M | 289.12M | 188.41M | 188.00M |
Cash, Cash Equivalents and Short-Term Investments | 685.85K | 672.79K | 790.93K | 431.58K | 519.59K | 661.20K |
Total Debt | 190.17M | 168.84M | 177.54M | 120.48M | 67.45M | 84.73M |
Total Liabilities | 280.65M | 262.38M | 259.26M | 196.30M | 110.80M | 123.21M |
Stockholders Equity | 111.35M | 111.73M | 104.17M | 92.83M | 77.61M | 64.79M |
Cash Flow | ||||||
Free Cash Flow | -7.13M | 47.44M | 8.16M | 8.20M | 19.41M | 11.85M |
Operating Cash Flow | 8.67M | 67.87M | 19.72M | 22.89M | 20.94M | 15.20M |
Investing Cash Flow | -43.77M | -42.11M | -66.27M | -14.36M | -1.47M | -13.31M |
Financing Cash Flow | 34.84M | -25.88M | 46.91M | -8.62M | -19.61M | -1.57M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $37.41B | 19.96 | 94.91% | 2.78% | 3.55% | -5.79% | |
77 Outperform | $18.14B | 36.03 | 11.16% | ― | 6.32% | 5.69% | |
76 Outperform | $13.87B | 36.99 | 9.05% | ― | 6.20% | -10.58% | |
71 Outperform | $900.39M | 2,245.98 | -1.38% | 3.31% | 0.26% | -119.66% | |
66 Neutral | £10.46B | 6.17 | 4.94% | 3.10% | -0.88% | 2.57% | |
64 Neutral | $74.55M | 48.08 | 1.35% | 0.62% | 6.03% | -83.00% | |
58 Neutral | $1.41B | ― | -4.11% | ― | 6.62% | 53.12% |